Company intelligence / Profile preview

Sense Relief

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Sense Relief has a commercially available Apple Watch/iPhone digital therapeutic app that delivers on-demand or automated acupressure-based nerve stimulation at the P6 acupoint to provide drug-free relief from nausea and vomiting, particularly for pregnancy-related nausea and vomiting; the company has received a UCSF-Stanford Pediatric Device Consortium grant to support further development and clinical study, but detailed trial outcomes and regulatory clearances are not publicly disclosed.[1][3][5][7]

Therapeutic areas: Women's HealthNeurologyPsychiatryGastroenterologyOncology
Modalities: DeviceNon-pharmacological therapyDigital therapeutic
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Sense Relief.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sense Relief.

Explore the full profile